Alambic Investment Management, L.P. - CONATUS PHARMACEUTICALS INC ownership

CONATUS PHARMACEUTICALS INC's ticker is CNAT and the CUSIP is 20600T108. A total of 60 filers reported holding CONATUS PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 0.32 and the average weighting 0.2%.

Quarter-by-quarter ownership
Alambic Investment Management, L.P. ownership history of CONATUS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2018$300,000
-73.5%
51,667
-80.5%
0.24%
-23.5%
Q2 2018$1,133,000
+123.9%
264,665
+207.0%
0.31%
+342.9%
Q1 2018$506,000
+6.8%
86,204
-15.9%
0.07%
+22.8%
Q4 2017$474,000
+203.8%
102,501
+259.7%
0.06%
+235.3%
Q3 2017$156,000
+27.9%
28,500
+35.1%
0.02%
+13.3%
Q2 2017$122,000
+130.2%
21,100
+14.1%
0.02%
-53.1%
Q4 2015$53,00018,5000.03%
Other shareholders
CONATUS PHARMACEUTICALS INC shareholders Q3 2018
NameSharesValueWeighting ↓
Kalos Management, Inc. 47,500$12,0000.01%
Virtu Financial LLC 94,842$25,0000.00%
ACADIAN ASSET MANAGEMENT LLC 467,425$121,0000.00%
REILLY FINANCIAL ADVISORS, LLC 22,011$6,0000.00%
A.R.T. Advisors, LLC 60,430$16,0000.00%
GOLDMAN SACHS GROUP INC 25,350$7,0000.00%
MORGAN STANLEY 1,019$00.00%
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM 24,900$6,0000.00%
WOLVERINE TRADING, LLC 30,900$8,0000.00%
WOLVERINE TRADING, LLC 26,779$7,0000.00%
View complete list of CONATUS PHARMACEUTICALS INC shareholders